 Candida glibrata is a major opportunistic fundal pathogen that causes both superficial and systemic infections in immunocompromised patients. It is also the second most common cause of Candidemia, making it important to understand its virulence and drug resistance mechanisms. Unlike Candida albicans, which can form filaments, C, glibrata is a haploid organism with a single chromosome and no ability to switch to filamentous growth. This makes it more difficult to treat than C, albicans, which is why it is important to develop effective antifundals against it. Additionally, C, glibrata is highly resistant to many antifundal drugs, including azoles, and can quickly become resistant to them if used for long periods of time. Furthermore, it can also use adhesion proteins to attach to host tissues and evade the host's immune system. Finally, C, glibrata can also enter host cells and persist there, making it even harder to treat. This article was authored by Carl Cuckler, Tobias Schwarzmuller, and Michael Strenner. We are article.tv. Links in the description below.